News from SGC

University of Toronto Researcher Opens Lab Notes in Real Time to Accelerate Research into Huntington's Disease

Posted on Friday 26th of February 2016

University of Toronto researcher Rachel Harding will be the first known biomedical researcher to welcome the world to review her lab notes in real time.

Alex Bullock: Understanding growth signals

Posted on Tuesday 16th of February 2016

Podcast: Meet our Researchers

Creating a New Drug Discovery Ecosystem in Oxford using Open Access

Posted on Tuesday 9th of February 2016

This month, we talk to Dr Wen Hwa Lee, Strategic Alliances Manager at the Structural Genomics Consortium (SGC), part of the Nuffield Department of Clinical Medicine, about how the SGC is revolutionising the way we think about drug discovery.

Stand Up To Cancer Canada Announces New Cancer Stem Cell Dream Team To Attack Brain Cancer in Children and Adults

Posted on Thursday 4th of February 2016

Pan-Canadian Team of Researchers Will Receive CA$11.7 Million in Funding from Stand Up To Cancer Canada, Genome Canada, Canadian Institutes of Health Research, Cancer Stem Cell Consortium, and Ontario Institute for Cancer Research

Myeloma UK and the SGC announce open-access collaboration to discover new drug targets for myeloma.

Posted on Tuesday 26th of January 2016

Myeloma UK and the Structural Genomics Consortium (SGC) have entered into an open-access research partnership to discover and characterise novel drug targets for myeloma using structural biology and chemical proteomics.

Registration now open: "Biological Methylation: Fundamental Mechanisms in Health and Disease"

Posted on Thursday 21st of January 2016

This SRC is focused on the role of Methylation Dynamics in nuclear and cytoplasmic biological processes and how this modification impacts development, epigenetic cellular identity, tissue homeostasis and disease.

DPhG Young Investigator Award for Kilian Huber

Posted on Tuesday 12th of January 2016

During DPhG Annual Meeting 2015 which took place in Düsseldorf September 23-25, 2015, the German Pharmaceutical Society honoured a few up-and-coming young scientists.

$5 million in funding for research into malaria and tuberculosis drug discovery

Posted on Wednesday 16th of December 2015

University of Toronto and McGill University scientists are leading an international partnership to discover new and improved drug treatments for tuberculosis, malaria and neglected tropical diseases -- thanks to a contribution from Merck Canada Inc., as well as an additional $5 million supplement to a grant from the Bill & Melinda Gates Foundation. The new funding brings the total investment from the Bill & Melinda Gates Foundation to nearly US $12 million since 2012.

Takeda renews partnership with Structural Genomics Consortium at MaRS Toronto with new investment of $7.5 million

Posted on Friday 4th of December 2015

Takeda Pharmaceutical Company Limited (Takeda) today announced it has renewed its partnership with the Structural Genomics Consortium (SGC) to fund collective drug research aimed at bringing new, more effective medicines to patients faster.